Genetic Leap
Genetic Leap is a clinical-stage biotech company innovating at the cutting edge of AI and RNA genetic medicine for in vivo reprogramming with oral medicines.
Listing updated
About Genetic Leap
Genetic Leap is a clinical-stage biotech company innovating at the cutting edge of AI and RNA genetic medicine for in vivo reprogramming with oral medicines. Its AI platform is described as proven to successfully reprogram RNA at its sequence using oligonucleotides or at its structure using small molecules, enabling a new generation of drugs.
The company reports that the FDA cleared an IND for a FIC, oral natural IL-2 modulator drug. It also lists an AI partnership for RNA-targeted genetic medicine development and a collaboration on AI for RNA-targeted small molecule design. Genetic Leap has offices in New York, NY and Singapore.
- Category
- Pharmaceutical lab
- Location
- Singapore
- Website
- genetic-leap.com
Summary written with AI from public business data. Disclaimer
Products & services
- AI platform for RNA reprogramming
- In vivo reprogramming with oral medicines
- RNA-targeted genetic medicine development
- RNA-targeted small molecule design
Tap a product to find other suppliers of it.
Location
Quick facts
- Business name
- Genetic Leap
- What it supplies
- Genetic Leap is listed under Pharmaceutical lab.
- Category
- Pharmaceutical lab
- Location
- Singapore
- Listed products and services
- AI platform for RNA reprogramming, In vivo reprogramming with oral medicines, RNA-targeted genetic medicine development, RNA-targeted small molecule design. (Summarised with AI from public business data.)
- How to contact
- Website and an enquiry form on this page.
- Listing last updated